• Markets
  • About Demcon
  • Companies
  • Creating Shared Value
  • Contact
  • career
  • news
  • press
  • en
  • nl
Demcon-grants
  1. Home›
  2. Press

press.

Here you will find information about social challenges, technological solutions and Demcon’s contribution. Acquaint yourself with the company and discover the story that underlies our technology. We are happy to provide you with all of the information you need for your article or program.

about Demcon.

We are working on solutions to social challenges. We do this by developing, manufacturing and supplying high-quality technology and innovative products. Demcon was created as a result of the passion of its founders for combining creativity and technical skills for the purpose of solving complex issues. Whether this concerns medical products, systems that monitor our security or sustainable solutions relating to themes such as water and energy, Demcon makes a contribution for current and future generations. In addition to developing technical solutions, we also focus our efforts on promoting entrepreneurship and investing in talent and education.

Opgericht
1993
established
Mensen
1100
employees
Vestigingen
11
locations in 4 countries
Bedirjven
16
Demcon companies

"we are happy to get in touch with you."

If you are interested in our work out of journalistic curiosity or if you would like to focus on Demcon for some other reason, contact us. We are happy to speak with you about our strategy, our technology and our social commitment. In addition, we are happy to bring you into contact with our specialists for an interview about a specific topic or project.

Marleen-Markvoort

Marleen Markvoort

+31 (0)88 115 20 00
send a message

press releases.

MedRingMedRing
Press

Demcon invests in LiGalli’s vaginal MdRing

Read more
fancy tweezersfancy tweezers
Press

Demcon invests in Mellon Medical’s surgical instrument

Read more
Press

First ventilation systems delivered by Demcon

Read more
blue machineeblue machinee
Press

Demcon invests in Alia Instruments: ‘From nuclear to non-nuclear’

Read more
cryosolcryosol
Press

Demcon invests in CryoSol technology for acceleration of research into ‘major’ diseases

Read more
View all items

news.

No results

MarketsAbout DemconCompaniesCreating Shared ValueCareerNewsPressEventsGrants

Contact us

Demcon headquarters
+31 88 115 20 00

send a message
cookie policyprivacy statement
© 2025 Demcon. All rights reserved.